Skip to Content
Also part of the UPMC family:
COVID-19 Vaccine in the Immunocompromised Study (CoVICS)

COVID-19 Vaccine in the Immunocompromised Study (CoVICS)

Many clinical studies have shown that vaccines are effective at preventing COVID-19. However, these studies did not include patients with weakened immune systems, so we do not yet know how well the vaccines will work in these people.

In the CoVICS study, we hope to determine how well immunocompromised patients respond to COVID-19 vaccines.

Am I Eligible to Participate?

You may be eligible if you:

  • Are age 18 or older
  • Are immunocompromised
  • Have received or are planning on receiving the COVID-19 vaccine

You are not eligible if:

  • Are not considered immunocompromised
  • Have been previously infected with COVID-19

Contact Information

For questions, contact or call 833-475-8215.

Register to Get Started

CoVICS Study Information

CoVICS is an observational study. Patients will not receive anything as a part of the study, such as medicine or treatment. Testing is free, and you will not be responsible for any out-of-pocket costs.

Staff will draw blood from participants. Less than one tablespoon of blood will be drawn each time, up to 5 times a year.

Blood can be drawn at several UPMC hospital labs. If you chose to participate, your blood can be drawn alone or at the same time as other bloodwork you have done at a clinic visit. Blood can be drawn via an intravenous line or port if you have one.

If you have already received your COVID-19 vaccine, we can draw your blood at any time, so long as it is at least one week after you have finished your vaccine doses. We will check your blood for antibodies against COVID-19 and your result will be released to you via MyUPMC.

If your sample shows that you have developed antibodies, we may contact you to provide more samples at months one, three, six, and twelve after your vaccine. We will look at how long your antibodies last and how they may change over time. These results will not be a part of your medical record. Please note, your blood samples may be used for additional testing via the UPMC Division of Infectious Diseases.

If you have not yet received your vaccine but are planning to do so, we may collect your first blood sample before your first or only dose and again after your vaccines, then at months one, three, six, and twelve.

Studying your blood over 12 months will help us understand how the immune response to COVID-19 vaccines changes over time. This is a voluntary study, and you may exit the study at any time.

Visits: At least 1, up to 5 optional

Duration: Up to 1 year


Open for Enrollment

Source(s) of Support:


Primary Investigator:

Ghady Haidar, MD